Caldwell Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Caldwell Trust's BIIB Position: Q2 2026 in Review
Caldwell Trust held its Biogen (BIIB) position steady in Q2 2026 at 383 shares worth $82.8K. The position accounts for 0.01% of the portfolio, ranked #436.
Caldwell Trust first reported a position in BIIB in Q4 2019 and has held it in 27 quarters since. The position peaked at $565K in Q4 2019. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Caldwell Trust held 383 shares of Biogen worth $82.8K as of Q2 2026.
- Caldwell Trust left its Biogen share count unchanged in Q2 2026.
- Biogen made up 0.01% of Caldwell Trust's portfolio in Q2 2026, its #436 holding.
- Caldwell Trust first reported a position in Biogen in Q4 2019 and has held it in 27 quarters since.
- Caldwell Trust's Biogen position peaked at $565K in Q4 2019.
- 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.